Tony Cheung

3.3k total citations · 1 hit paper
39 papers, 1.7k citations indexed

About

Tony Cheung is a scholar working on Epidemiology, Oncology and Molecular Biology. According to data from OpenAlex, Tony Cheung has authored 39 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 13 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Tony Cheung's work include Viral-associated cancers and disorders (10 papers), Cytomegalovirus and herpesvirus research (8 papers) and Lymphoma Diagnosis and Treatment (8 papers). Tony Cheung is often cited by papers focused on Viral-associated cancers and disorders (10 papers), Cytomegalovirus and herpesvirus research (8 papers) and Lymphoma Diagnosis and Treatment (8 papers). Tony Cheung collaborates with scholars based in United States, Australia and United Kingdom. Tony Cheung's co-authors include Aaron J. Marcus, Harold S. Ballard, Bharat N. Nathwani, Steven Teich, Andrew D. Ferguson, Huawei Chen, Jiaquan Wu, Anil Tulpule, S. C. Remick and Bruce J. Dezube and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Tony Cheung

39 papers receiving 1.6k citations

Hit Papers

KAPOSI'S SARCOMA IN HOMOSEXUAL MEN—A REPORT OF EIGHT CASES 1981 2026 1996 2011 1981 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tony Cheung United States 22 622 558 426 380 313 39 1.7k
Roberto Bugarini Italy 23 649 1.0× 817 1.5× 371 0.9× 626 1.6× 377 1.2× 44 2.4k
Fayez M. Hamzeh United States 22 482 0.8× 986 1.8× 191 0.4× 388 1.0× 209 0.7× 42 1.7k
Jack R. Davis United States 17 608 1.0× 344 0.6× 181 0.4× 401 1.1× 228 0.7× 32 1.6k
Laurent Bélec France 19 212 0.3× 724 1.3× 488 1.1× 439 1.2× 97 0.3× 54 1.9k
Jean Marie Arduino United States 18 245 0.4× 490 0.9× 523 1.2× 614 1.6× 257 0.8× 37 1.8k
Nathalie Franck France 17 789 1.3× 584 1.0× 239 0.6× 251 0.7× 261 0.8× 34 1.7k
Jean‐Louis Touraine France 24 365 0.6× 483 0.9× 322 0.8× 670 1.8× 131 0.4× 72 2.4k
Rajesh Kannangai India 23 343 0.6× 956 1.7× 929 2.2× 534 1.4× 232 0.7× 134 2.5k
C Mayaud France 27 444 0.7× 854 1.5× 132 0.3× 449 1.2× 170 0.5× 79 2.1k
Eva A. Operskalski United States 24 660 1.1× 983 1.8× 86 0.2× 816 2.1× 206 0.7× 42 2.1k

Countries citing papers authored by Tony Cheung

Since Specialization
Citations

This map shows the geographic impact of Tony Cheung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tony Cheung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tony Cheung more than expected).

Fields of papers citing papers by Tony Cheung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tony Cheung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tony Cheung. The network helps show where Tony Cheung may publish in the future.

Co-authorship network of co-authors of Tony Cheung

This figure shows the co-authorship network connecting the top 25 collaborators of Tony Cheung. A scholar is included among the top collaborators of Tony Cheung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tony Cheung. Tony Cheung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Collie, Gavin W., Cheryl M. Koh, Daniel O’Neill, et al.. (2019). Structural and Molecular Insight into Resistance Mechanisms of First Generation cMET Inhibitors. ACS Medicinal Chemistry Letters. 10(9). 1322–1327. 39 indexed citations
2.
Cheung, Tony & Steven Teich. (2019). Cytomegalovirus Infection in Patients With HIV-1 Infection. Case Medical Research. 66(2). 113–24. 25 indexed citations
3.
Ma, Rui, Ling Xu, Xiujuan Qu, et al.. (2018). AZ304, a novel dual BRAF inhibitor, exerts anti-tumour effects in colorectal cancer independently of BRAF genetic status. British Journal of Cancer. 118(11). 1453–1463. 12 indexed citations
4.
Wu, Jiaquan, Tony Cheung, Andrew D. Ferguson, et al.. (2011). Biochemical Characterization of Human SET and MYND Domain-Containing Protein 2 Methyltransferase. Biochemistry. 50(29). 6488–6497. 42 indexed citations
5.
Ferguson, Andrew D., Nicholas Larsen, Tina Howard, et al.. (2011). Structural Basis of Substrate Methylation and Inhibition of SMYD2. Structure. 19(9). 1262–1273. 154 indexed citations
6.
Buchanan, Malcolm S., Anthony R. Carroll, Gregory A. Fechner, et al.. (2008). Small-molecule inhibitors of the cancer target, isoprenylcysteine carboxyl methyltransferase, from Hovea parvicalyx. Phytochemistry. 69(9). 1886–1889. 18 indexed citations
9.
Besien, Koen van, Steven M. Devine, Amittha Wickrema, et al.. (2003). Safety and outcome after fludarabine–thiotepa–TBI conditioning for allogeneic transplantation: a prospective study of 30 patients with hematologic malignancies. Bone Marrow Transplantation. 32(1). 9–13. 7 indexed citations
11.
Richardson, Max W., et al.. (2000). Analysis of telomere length and thymic output in fast and slow/non-progressors with HIV infection. Biomedicine & Pharmacotherapy. 54(1). 21–31. 26 indexed citations
12.
El‐Sadr, Wafaa, Robert L. Murphy, Roberta Luskin‐Hawk, et al.. (1998). Atovaquone Compared with Dapsone for the Prevention ofPneumocystis cariniiPneumonia in Patients with HIV Infection Who Cannot Tolerate Trimethoprim, Sulfonamides, or Both. New England Journal of Medicine. 339(26). 1889–1895. 120 indexed citations
13.
Dezube, Bruce J., Jamie H. Von Roenn, Jeanne Holden‐Wiltse, et al.. (1998). Fumagillin analog in the treatment of Kaposi's sarcoma: a phase I AIDS Clinical Trial Group study. AIDS Clinical Trial Group No. 215 Team.. Journal of Clinical Oncology. 16(4). 1444–1449. 109 indexed citations
14.
Lalezari, Jacob, Judith Feinberg, Joseph Gathe, et al.. (1997). A Randomized, Double‐Blind, Placebo‐Controlled Trial of Cidofovir Gel for the Treatment of Acyclovir‐Unresponsive Mucocutaneous Herpes Simplex Virus Infection in Patients with AIDS. The Journal of Infectious Diseases. 176(4). 892–898. 114 indexed citations
15.
Roenn, Jamie H. Von, S. C. Remick, Timothy P. Cooley, et al.. (1997). FUMAGILLIN ANALOG (TNP-470) IN THE TREATMENT OF KAPOSI'S SARCOMA. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 14(4). A35–A35. 5 indexed citations
16.
Mendelson, Meryl H., Alejandra Gurtman, Susan Szabo, et al.. (1994). Pseudomonas aeruginosa Bacteremia in Patients with AIDS. Clinical Infectious Diseases. 18(6). 886–895. 112 indexed citations
17.
Jacobson, Mark Z., Michael Wulfsohn, Judith Feinberg, et al.. (1994). Phase II dose-ranging trial of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients intolerant of or resistant to ganciclovir (ACTG Protocol 093). AIDS. 8(4). 451–460. 17 indexed citations
18.
Cheung, Tony, Raymond J. Matta, Eric Neibart, et al.. (1993). Intramuscular Pentamidine for the Prevention of Pneumocystis carinii Pneumonia in Patients Infected with Human Immunodeficiency Virus. Clinical Infectious Diseases. 16(1). 22–25. 11 indexed citations
19.
Teich, Steven, Tony Cheung, & Alan H. Friedman. (1992). Systemic antiviral drugs used in ophthalmology. Survey of Ophthalmology. 37(1). 19–53. 26 indexed citations
20.
Cheung, Tony. (1990). The Costs of HIV Infections. JAMA. 263(8). 1067–1067. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026